QK1 Antibody (YA7675)

(Synonyms: HKQ, QKI, KH domain-containing RNA-binding protein QKI, Protein quaking, Hqk, HqkI)
Customer Review

Based on 1 Customer Validation

QK1 Antibody (YA7675) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to QK1.

For research use only. We do not sell to patients.
  • Host:

    Rabbit

  • Isotype:

    IgG

  • Application:

    WB, ICC/IF, IP, FC

  • Reactivity :

    Human, Mouse

  • Formulation:

    Supplied in 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol.

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
IP Info
IP: Immunoprecipitation
FC Info
FC: Flow Cytometry
Dilution Ratio 1:500-2000 1:50-200 1:20-50 1:50-100

Product Details

Description

QK1 Antibody (YA7675) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to QK1.

  • Host Rabbit
  • Clonality Recombinant
  • Species Reactivity
    Human, Mouse
  • Observed Molecular Weight
    Observed band size: 42 kDa Info
    Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
  • Calculated Molecular Weight Predicted band size: 38 kDa
Immunogen

A synthesized peptide derived from human QKI: 270-341.

Sensitivity

Endogenous

Purification

affinity purified by Protein A

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG

Product Properties

  • Appearance

    Solution

  • Formulation

    Supplied in 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol.

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    QK1 is a RNA reader protein, which recognizes and binds specific RNAs, thereby regulating RNA metabolic processes, such as pre-mRNA splicing, circular RNA (circRNA) formation, mRNA export, mRNA stability and/or translation. Involved in various cellular processes, such as mRNA storage into stress granules, apoptosis, lipid deposition, interferon response, glial cell fate and development. Binds to the 5'-NACUAAY-N(1,20)-UAAY-3' RNA core sequence. Acts as a mRNA modification reader that specifically recognizes and binds mRNA transcripts modified by internal N(7)-methylguanine (m7G). Promotes the formation of circular RNAs (circRNAs) during the epithelial to mesenchymal transition and in cardiomyocytes: acts by binding to sites flanking circRNA-forming exons. CircRNAs are produced by back-splicing circularization of pre-mRNAs. Plays a central role in myelinization via 3 distinct mechanisms. First, acts by protecting and promoting stability of target mRNAs such as MBP, SIRT2 and CDKN1B, which promotes oligodendrocyte differentiation. Second, participates in mRNA transport by regulating the nuclear export of MBP mRNA. Finally, indirectly regulates mRNA splicing of MAG pre-mRNA during oligodendrocyte differentiation by acting as a negative regulator of MAG exon 12 alternative splicing: acts by binding to HNRNPA1 mRNA splicing factor, preventing its translation. Involved in microglia differentiation and remyelination by regulating microexon alternative splicing of the Rho GTPase pathway. Involved in macrophage differentiation: promotes monocyte differentiation by regulating pre-mRNA splicing in naive peripheral blood monocytes. Acts as an important regulator of muscle development: required for the contractile function of cardiomyocytes by regulating alternative splicing of cardiomyocyte transcripts. Acts as a negative regulator of thermogenesis by decreasing stability, nuclear export and translation of mRNAs encoding PPARGC1A and UCP1. Also required for visceral endoderm function and blood vessel development. May also play a role in smooth muscle development. In addition to its RNA-binding activity, also acts as a nuclear transcription coactivator for SREBF2/SREBP2|Nuclear isoform that acts as an indirect regulator of mRNA splicing. Regulates mRNA splicing of MAG pre-mRNA by inhibiting translation of HNRNPA1 mRNA, thereby preventing MAG exon 12 alternative splicing. Involved in oligodendrocyte differentiation by promoting stabilization of SIRT2 mRNA. Acts as a negative regulator of the interferon response by binding to MAVS mRNA, downregulating its expression. Also inhibits the interferon response by binding to fibrinectin FN1 pre-mRNA, repressing EDA exon inclusion in FN1. Delays macrophage differentiation by binding to CSF1R mRNA, promoting its degradation. In addition to its RNA-binding activity, also acts as a nuclear transcription coactivator for SREBF2/SREBP2, promoting SREBF2/SREBP2-dependent cholesterol biosynthesis. SREBF2/SREBP2-dependent cholesterol biosynthesis participates to myelinization and is required for eye lens transparency|Cytosolic isoform that specifically recognizes and binds mRNA transcripts modified by internal N(7)-methylguanine (m7G). Interaction with G3BP1 promotes localization of m7G-containing mRNAs into stress granules in response to stress, thereby suppressing their translation. Acts as a translational repressor for HNRNPA1 and GLI1. Translation inhibition of HNRNPA1 during oligodendrocyte differentiation prevents inclusion of exon 12 in MAG pre-mRNA splicing. Involved in astrocyte differentiation by regulating translation of target mRNAs|Cytosolic isoform that specifically recognizes and binds mRNA transcripts modified by internal N(7)-methylguanine (m7G). Interaction with G3BP1 promotes localization of m7G-containing mRNAs into stress granules in response to stress, thereby suppressing their translation. Acts as a negative regulator of angiogenesis by binding to mRNAs encoding CDH5, NLGN1 and TNFAIP6, promoting their degradation. Can also induce apoptosis in the cytoplasm. Heterodimerization with other isoforms results in nuclear translocation of isoform QKI7 and suppression of apoptosis. Also binds some microRNAs: promotes stabilitation of miR-122 by mediating recruitment of poly(A) RNA polymerase TENT2, leading to 3' adenylation and stabilization of miR-122[1][2][3][4][5][6][7][8][9][10][11].

  • Subcellular Localization

    Nucleus,Cytoplasm,Nucleus,Cytoplasm,Cytoplasm, cytosol,Nucleus,Cytoplasm, cytosol,Cytoplasm, Stress granule,Nucleus

  • Expression


    Tissue_Specificity: Expressed in the frontal cortex of brain. Down-regulated in the brain of schizophrenic patients
    Induction: Expression is activated by CEBPA furing macrophage differentiation

  • Isoforms & Post-Translational Modification

    Q96PU8 has 6 isomers: Q96PU8-1: 37671 Da (predicted); Q96PU8-3: 36926 Da (predicted); Q96PU8-5: 35233 Da (predicted); Q96PU8-6: 35978 Da (predicted); Q96PU8-8: 35248 Da (predicted); Q96PU8-9: 35131 Da (predicted).
    Methylated by PRMT1丨Tyrosine phosphorylated at its C-terminus, probably by FYN丨Ubiquitinated by RNF6 in macrophages, leading to its degradation

  • Subunit

    Homodimer; does not require RNA to homodimerize (PubMed:23630077)

  • SwissProt ID

    Q96PU8

  • Synonyms

    HKQ, QKI, KH domain-containing RNA-binding protein QKI, Protein quaking, Hqk, HqkI

References

[1]. Fu H, et al. The RNA-binding protein QKI5 is a direct target of C/EBPα and delays macrophage differentiation. Mol Biol Cell. 2012 May;23(9):1628-35. [Content Brief]

[2]. Teplova M, et al. Structure-function studies of STAR family Quaking proteins bound to their in vivo RNA target sites. Genes Dev. 2013 Apr 15;27(8):928-40. [Content Brief]

[3]. Conn SJ, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015 Mar 12;160(6):1125-34. [Content Brief]

[4]. de Bruin RG, et al. Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression. Nat Commun. 2016 Mar 31;7:10846. [Content Brief]

[5]. Caines R, et al. The RNA-binding protein QKI controls alternative splicing in vascular cells, producing an effective model for therapy. J Cell Sci. 2019 Aug 15;132(16):. [Content Brief]

[6]. Zhao Z, et al. QKI shuttles internal m(7)G-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023 Jul 20;186(15):3208-3226.e27. [Content Brief]

[7]. Liao KC, et al. The RNA binding protein Quaking represses host interferon response by downregulating MAVS. RNA Biol. 2020 Mar;17(3):366-380. [Content Brief]

[8]. Liao KC, et al. The RNA binding protein Quaking represses splicing of the Fibronectin EDA exon and downregulates the interferon response. Nucleic Acids Res. 2021 Sep 27;49(17):10034-10045. [Content Brief]

[9]. Aberg K, et al. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci U S A. 2006 May 9;103(19):7482-7. [Content Brief]

[10]. Yang C, et al. Targeting QKI-7 in vivo restores endothelial cell function in diabetes. Nat Commun. 2020 Jul 30;11(1):3812. [Content Brief]

[11]. Hojo H, et al. The RNA-binding protein QKI-7 recruits the poly(A) polymerase GLD-2 for 3' adenylation and selective stabilization of microRNA-122. J Biol Chem. 2020 Jan 10;295(2):390-402. [Content Brief]

View More

QK1 Antibody (YA7675) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00